Dimethyl Sulfoxide → 3-(2,6-dichlorophenyl)-7-methanesulfonyl-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one

HRID 1858199Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1858199
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([Cl:8])[C:3]=1[N:9]1[CH2:18][C:17]2[C:12](=[N:13]C(SC)=[N:15][CH:16]=2)[NH:11][C:10]1=[O:21].ClC1C=CC=C(C(OO)=[O:30])C=1.[CH3:33][S:34]([CH3:36])=[O:35].C(=O)(O)[O-].[Na+]>ClCCl>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([Cl:8])[C:3]=1[N:9]1[CH2:18][C:17]2[C:12](=[N:13][C:33]([S:34]([CH3:36])(=[O:30])=[O:35])=[N:15][CH:16]=2)[NH:11][C:10]1=[O:21]

Komponenten

6

Versuchsvorschrift

A solution of 220 mg (0.64 mmol) of 3-(2,6-dichlorophenyl)-7-methylthio-3,4-dihydropyrimido[4,5-d]pyrimidine-2(1H)-one in 10 ml of dichloromethane was treated with 440 mg (1.28 mmol) of 3-chloroperbenzoic acid (50% w/w in water) and stirred for 18 hours. 0.2 ml of dimethyl sulfoxide was added. After a further 15 minutes 15 ml of saturated aqueous sodium bicarbonate solution were added. The phases were separated and then the organic phase was washed with 30 ml of saturated aqueous sodium bicarbonate solution, dried over magnesium sulfate and evaporated to give 250 mg (100%) of 3-(2,6-dichlorophenyl)-7-methanesulfonyl-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one as a white solid.

Aufarbeitung

  1. customThe phases were separated
  2. washthe organic phase was washed with 30 ml of saturated aqueous sodium bicarbonate solution
  3. dry with materialdried over magnesium sulfate
  4. customevaporated

Quellen und Nachweise

ORD-Eintrag
ord-1cde9ece6bea41669b2a830071cc5d28
Quelldatensatz
uspto-grants-2000_11
Patentnummer
US06150373

Notizen zur Reaktion

Wird geladen…